A RESOLUTION ADOPTING THE INTERIM GUIDELINES FOR THE IMPLEMENTATION OF CY 2023 MEASLES RUBELLA AND BIVALENT ORAL POLIOVIRUS VACCINE SUPPLEMENTARY IMMUNIZATION ACTIVITIES
(MR-BOPV SIA)